Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [31] Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer
    Nomura, Hidetaka
    Ikki, Ai
    Fusegi, Atsushi
    Omi, Makiko
    Aoki, Yoichi
    Netsu, Sachiho
    Tanigawa, Terumi
    Matoda, Maki
    Okamoto, Sanshiro
    Omatsu, Kohei
    Nakajima, Takeshi
    Ueki, Arisa
    Tonooka, Akiko
    Kanao, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (12) : 2331 - 2337
  • [32] MRI breast screening in high-risk women: cancer detection and survival analysis
    Gareth, Evans D.
    Nisha, Kesavan
    Yit, Lim
    Soujanye, Gadde
    Emma, Hurley
    Massat, Nathalie J.
    Maxwell, Anthony J.
    Sarah, Ingham
    Rosalind, Eeles
    Leach, Martin O.
    Anthony, Howell
    Stephen, Duffy
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) : 663 - 672
  • [33] Update on Screening Breast MRI in High-Risk Women
    Boetes, C.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2010, 18 (02) : 241 - +
  • [34] Fatigue and Quality of Life After Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Hereditary Breast-Ovarian Cancer
    Michelsen, Trond M.
    Dorum, Anne
    Trope, Claes G.
    Fossa, Sophie D.
    Dahl, Alv A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1029 - 1036
  • [35] Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer
    Meiser, Bettina
    Price, Melanie A.
    Butow, Phyllis N.
    Karatas, Janan
    Wilson, Judy
    Heiniger, Louise
    Baylock, Brandi
    Charles, Margaret
    McLachlan, Sue-Anne
    Phillips, Kelly-Anne
    FAMILIAL CANCER, 2013, 12 (01) : 101 - 109
  • [36] Radiological screening of breast cancer in women at high risk
    Guzman, Gonzalo Jose Romero
    Franjo, Esther Dominguez
    de Las Vacas, Maria Isabel Diez Perez
    Borge, Natalia Alegre
    Bejarano, Daniel Augusto Puentes
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2021, 34 (01): : 37 - 43
  • [37] Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer
    Bae, Min Sun
    Sung, Janice S.
    Bernard-Davila, Blanca
    Sutton, Elizabeth J.
    Comstock, Christopher E.
    Morris, Elizabeth A.
    JOURNAL OF BREAST IMAGING, 2020, 2 (01) : 29 - 35
  • [38] Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer
    Sutherland, Sarah
    Meiser, Bettina
    Kaur, Rajneesh
    Mitchell, Gillian
    Kirk, Judy
    Peate, Michelle
    Wong, W. K. Tim
    Goodwin, Annabel
    BREAST JOURNAL, 2019, 25 (01) : 34 - 40
  • [39] Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing
    Murphy, Brittany L.
    Yi, Min
    Arun, Banu K.
    Barrera, Angelica M. Gutierrez
    Bedrosian, Isabelle
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4613 - 4621
  • [40] The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review
    Roeke, Toni
    van Bommel, Annelotte C. M.
    Gaillard-Hemmink, Marlien P.
    Hartgrink, Henk H.
    Mesker, Wilma E.
    Tollenaar, Rob A. E. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 15 - 23